Please use this identifier to cite or link to this item:
http://hdl.handle.net/11054/2015
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Lindsay, J. | en_US |
dc.contributor | Greenwood, M. | en_US |
dc.contributor | Othman, J. | en_US |
dc.contributor | Chen, S. | en_US |
dc.contributor | Kong, David C. M. | en_US |
dc.contributor | Pergam, S. | en_US |
dc.contributor | Liu, C. | en_US |
dc.contributor | Slavin, M. | en_US |
dc.date.accessioned | 2022-12-16T02:06:59Z | - |
dc.date.available | 2022-12-16T02:06:59Z | - |
dc.date.issued | 2022 | - |
dc.identifier.govdoc | 01969 | en_US |
dc.identifier.uri | http://hdl.handle.net/11054/2015 | - |
dc.description.provenance | Submitted by Gemma Siemensma (gemmas@bhs.org.au) on 2022-12-05T04:27:43Z No. of bitstreams: 0 | en |
dc.description.provenance | Approved for entry into archive by Gemma Siemensma (gemmas@bhs.org.au) on 2022-12-16T02:06:59Z (GMT) No. of bitstreams: 0 | en |
dc.description.provenance | Made available in DSpace on 2022-12-16T02:06:59Z (GMT). No. of bitstreams: 0 Previous issue date: 2022 | en |
dc.title | Treatment failure cost analysis of Cytomegalovirus (CMV) management in allogeneic hematopoietic cell transplantation. | en_US |
dc.type | Journal Article | en_US |
dc.type.specified | Article | en_US |
dc.bibliographicCitation.title | Leukemia & Lymphoma | en_US |
dc.bibliographicCitation.volume | 63 | en_US |
dc.bibliographicCitation.issue | 9 | en_US |
dc.bibliographicCitation.stpage | 2254 | en_US |
dc.bibliographicCitation.endpage | 2256 | en_US |
dc.subject.healththesaurus | CYTOMEGALOVIRUS | en_US |
dc.subject.healththesaurus | HEMATOPOIETIC CELL TRANSPLANTATION | en_US |
dc.subject.healththesaurus | COST ANAL:YSIS | en_US |
dc.identifier.doi | https://doi.org/10.1080/10428194.2022.2064992 | en_US |
Appears in Collections: | Research Output |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.